Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BMP Pharma Trading AGSTU:BMP 36 PB Ratio is 3.66 as of Aug. 01, 2026, which is 213% above its 10-year median of 1.17. GuruFocus rates STU:BMP with a GF Score™ of 36/100. The stock has 2 warning signs investors should review. Among 112 Medical Distribution companies, BMP Pharma Trading AG ranks worse than 84.82% on this metric.
The historical rank and industry rank for BMP Pharma Trading AG's PB Ratio or its related term are showing as below:
STU:BMP'
s PB Ratio Range Over the Past 10 Years
Min: 0.41 Med: 1.17 Max: 4.88
Current: 3.66
During the past 13 years, BMP Pharma Trading AG's highest PB Ratio was 4.88. The lowest was 0.41. And the median was 1.17.
STU:BMP's PB Ratio is ranked worse than 84.82% of 112
companies
in the Medical Distribution industry
Industry Median: 1
vs STU:BMP: 3.66
During the past 12 months, BMP Pharma Trading AG's average Book Value Per Share Growth Rate was -0.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -4.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 5.40% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 7.60% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of BMP Pharma Trading AG was 19.80% per year. The lowest was -4.40% per year. And the median was 5.10% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, BMP Pharma Trading AG's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BMP Pharma Trading AG PB Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, BMP Pharma Trading AG's PB Ratio distribution charts can be found below:
* The bar in red indicates where BMP Pharma Trading AG's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
BMP Pharma Trading AG (STU:BMP) has a PB Ratio of 3.66 as of Aug. 01, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on BMP Pharma Trading AG and its competitors. This is 213% above median its historical median of 1.17. Over the past decade, BMP Pharma Trading AG's PB Ratio has ranged from 0.41 to 4.88. According to the industry distribution chart, BMP Pharma Trading AG ranks #95 out of 112 companies in the Medical Distribution industry, placing it in the top 84.8%.
Is BMP Pharma Trading AG's PB Ratio too high?
BMP Pharma Trading AG's current PB Ratio of 3.66 is 213% above median its 10-year median of 1.17. Over the past 10 years, this metric has ranged from a low of 0.41 to a high of 4.88. The Medical Distribution industry median PB Ratio is 1.00. BMP Pharma Trading AG's value of 3.66 is 266% above this industry median. Based on the distribution chart, BMP Pharma Trading AG ranks #95 out of 112 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, BMP Pharma Trading AG has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does BMP Pharma Trading AG's PB Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, BMP Pharma Trading AG ranks #95 out of 112 companies for PB Ratio. This places BMP Pharma Trading AG in the lower half of its industry. The industry median PB Ratio is 1.00. BMP Pharma Trading AG's value of 3.66 is 266% above this benchmark. Historically, BMP Pharma Trading AG's own PB Ratio has ranged from 0.41 to 4.88 over the past decade. While the company's 10-year median is 1.17 vs. the industry median of 1.00, BMP Pharma Trading AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Distribution company?
The median PB Ratio among Medical Distribution companies is 1.00, based on 112 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BMP Pharma Trading AG's current PB Ratio of 3.66 is 266% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on BMP Pharma Trading AG and its competitors. For the Medical Distribution industry, the median PB Ratio is 1.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BMP Pharma Trading AG's current PB Ratio is 3.66, which is 213% above median its own 10-year median of 1.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BMP Pharma Trading AG stock overvalued right now?
BMP Pharma Trading AG (STU:BMP) has a current PB Ratio of 3.66. The current PB Ratio is 3.66, which is 213% above median its 10-year median of 1.17 and 266% above the Medical Distribution industry median of 1.00. BMP Pharma Trading AG's overall GF Score™ is 36/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For BMP Pharma Trading AG (STU:BMP), the current PB Ratio is 3.66 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BMP Pharma Trading AG is a German company engaged in trading of pharmaceutical raw materials, food supplement products, and veterinary raw materials. The services offered by the company include development of microbial processes, Transfer of biotechnological processes, Contract production of biotechnologically and biocatalysts and development of chiral syntheses.
36GF Score
Get the complete analysis for STU:BMP
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:BMP has been successfully added to your 
